Vertex Pharmaceuticals (VRTX) slumps on Q4 loss

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares dropped 6.4% to $113.48. Vertex Pharma reported Q4 adjusted loss of $0.55 per share. Share volume was 2.6 million, compared to an all-day average of 1.5 million